ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673104 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673104; 2) Community: the network communities that were significantly associated with the response to NSC 673104; 3) Molecule: the relationships between components within communities and NSC 673104; 4) MDR: the compounds that were significantly associated with the NSC 673104.

NSC Compound Enrichment Correlation
NSC 158088 Null 0.0366216145653011 -0.114542
NSC 187546 Ethanimidamide, 2-chloro-N-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-, monohydrochloride 0.0366216145653011 -0.22761677
NSC 315626 Butyric acid, rhodium salt (4:2) 0.0366216145653011 -0.16602236
NSC 34927 Null 0.0366216145653011 -0.11147069
NSC 365798 Fostamatinib disodium, Tamatinib fosdium 0.0366216145653011 0.038681716
NSC 510656 Benzonitrile, 2-amino-3,5-dinitro- (9CI) 0.0366216145653011 0.040014275
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.0366216145653011 0.14258782
NSC 619837 Null 0.0366216145653011 -0.14713032
NSC 622294 Null 0.0366216145653011 -0.05179016
NSC 643248 23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2 0.0366216145653011 0.34844909
Total:50  Current:35    [First] [Prev] [Next] [Last]